➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Merck
Baxter
Medtronic
Dow

Last Updated: March 4, 2021

DrugPatentWatch Database Preview

Hydrocortisone sodium succinate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for hydrocortisone sodium succinate and what is the scope of freedom to operate?

Hydrocortisone sodium succinate is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Abraxis Pharm, Baxter Hlthcare, Intl Medication, Watson Labs, and Pharmacia And Upjohn, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-seven drug master file entries for hydrocortisone sodium succinate. Three suppliers are listed for this compound.

Summary for hydrocortisone sodium succinate
Recent Clinical Trials for hydrocortisone sodium succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto do CoracaoPhase 3
IMSS Hospital General de Zona 11, Piedras NegrasPhase 3
Emory UniversityPhase 3

See all hydrocortisone sodium succinate clinical trials

Pharmacology for hydrocortisone sodium succinate

US Patents and Regulatory Information for hydrocortisone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085932-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 084738-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088667-001 Jun 8, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Dow
AstraZeneca
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.